All webinar times are in Eastern Time except where noted. Convert to your time zone
Register for this webinar to learn about the novel technology of full-field digital cell morphology. With your registration, you will have access to the recording on demand through July 31, 2022.
Do you dare to imagine an all-digital workflow for blood smears review? If your answer is "yes", join Dr. Olga Pozdnyakova for an introduction to the novel full-field digital technology and its comparison to the current state of manual and digital technologies for microscopy applications. Dr. Pozdnyakova will present the results of a multi-institutional FDA clinical trial, including representative full field peripheral blood smear (FFM-PBS) cans, simulating comprehensive morphological analysis of real-life blood smears, and the clinical benefits of this innovative approach.
Full field digital cell morphology represents true progress in standardization, efficiency, remote workflow capability, and scalability of hematological examination. It fundamentally changes laboratory practice and closes the gap between the manual and digital microscopic PBS review.
This activity is designed for physicians, lab supervisors, lab directors (and/or assistant directors), lab managers (supervisory and/or non-supervisory), medical technologists, pathologists, fellows, residents, in-training individuals, hematopathologists, hematologists, and hemato-oncologists.
At the end of this activity, participants will be able to:
- Recognize the limitations/challenges of manual microscopy and current digital solutions in pathology and clinical laboratories
- Summarize the clinical benefits of a full field digital cell morphology approach for peripheral blood smear review
- Implement full field digital solutions in clinical practice
Olga Pozdnyakova, MD, PhD
Associate Professor, Harvard Medical School
Medical Director of Hematology Laboratory, Brigham and Women's Hospital
DISCLOSURES AND STATEMENT OF INDEPENDENCE
AACC is dedicated to ensuring balance, independence, objectivity, and scientific rigor in all educational activities. All participating planning committee members and faculty are required to disclose to the program audience any financial relationships related to the subject matter of this program. Disclosure information is reviewed in advance in order to manage and resolve any possible conflicts of interest. The intent of this disclosure is to provide participants with information on which they can make their own judgments.
The following faculty reported the following relevant financial relationship(s) during the content development process for this activity:
Olga Pozdnyakova, MD, PhD
- Consultant Fee: Scopio; Hoffman La Roche
- Presenter/Speaker: Scopio
All recommendations involving clinical medicine are based on evidence accepted within the profession of medicine as adequate justification for their indications and contraindications in the care of patients AND/OR All scientific research referred to or reported in support or justification of a patient care recommendation conforms to generally accepted standards of experimental design, data collection, and analysis.
This activity is approved for 1.0 ACCENT® continuing education credits. Activity ID# 2137. This activity was planned in accordance with ACCENT® Standards and Policies.
Release date: July 20, 2021
Credit valid through: July 31, 2022
SUCCESSFUL COMPLETION STATEMENT
Verification of Participation certificates are provided to registered participants based on completion of the activity, in its entirety, and the activity evaluation. For questions regarding continuing education, please email [email protected].